Genyang Cheng

机构：Zhengzhou University, First Affiliated Hospital of Zhengzhou University · ORCID：0000-0003-4518-271X

发表论文 66 篇 · 总被引 778 次 · h-index 17

代表论文

• Impact of antimalarial (AM) on serum lipids in systemic lupus erythematosus (SLE) patients (2019 · Medicine · 被引 26)
• Identification of key lncRNAs contributing to diabetic nephropathy by gene co-expression network analysis (2019 · Scientific Reports · 被引 24)
• Preliminary study on the application of renal ultrasonography radiomics in the classification of glomerulopathy (2021 · BMC Medical Imaging · 被引 22)
• Folic acid-targeted pluronic F127 micelles improve oxidative stress and inhibit fibrosis for increasing AKI efficacy (2022 · European Journal of Pharmacology · 被引 17)
• Compound C Protects Against Cisplatin-Induced Nephrotoxicity Through Pleiotropic Effects (2020 · Frontiers in Physiology · 被引 16)
• Dual-targeted nanoparticles with removing ROS inside and outside mitochondria for acute kidney injury treatment (2023 · Nanomedicine Nanotechnology Biology and Medicine · 被引 15)